Sun Pharmaceutical Industries has announced that one of its wholly-owned subsidiaries has launched a novel anti-cancer drug, Palbociclib, in India for patients who have advanced breast cancer, the most common cancer among women in the country. The company said it would make the drug available under the brand name, Palenotm (Palbociclib) for 75 mg, 100 mg and 125 mg.
About the Author
